http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112851752-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 |
| filingDate | 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112851752-B |
| titleOfInvention | Human milk endogenous antibacterial polypeptide and application thereof in preparation of anti-inflammatory drugs |
| abstract | The invention relates to a polypeptide compound YEKYLGPQYV which is derived from human milk endogenous source and has inhibitory activity on gram-positive bacteria and gram-negative bacteria represented by escherichia coli and staphylococcus aureus, and the amino acid sequence of the polypeptide compound is Tyr-Glu-Lys-Tyr-Leu-Gly-Pro-Gln-Tyr-Val. The polypeptide YEKYLGPQYV has broad inhibitory activity on gram-positive bacteria and gram-negative bacteria, and has good application prospect as a medicament and/or health product for preventing and/or reducing intestinal infection diseases of newborns caused by microorganisms or an additive of novel infant formula food. |
| priorityDate | 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.